Nolato AB (publ) (STO:NOLA.B)
Sweden · Delayed Price · Currency is SEK 52.00
+0.30 (0.58%)
Apr 14, 2026, 2:46 PM CET
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 13.95 billion as of April 14, 2026. Its market cap has decreased by -13.09% in one year.
Market Cap
13.95B
Enterprise Value
14.93B
Revenue
9.46B
Ranking
n/a
PE Ratio
17.99
Stock Price
52.00
Market Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 13.95B, an increase of 2,013.20%. That is a compound annual growth rate of 10.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 13.93B | -16.34% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 52.28B |
| Sectra AB | 46.20B |
| Elekta AB | 21.15B |
| Vitrolife AB | 13.45B |
| Xvivo Perfusion AB | 8.43B |
| MedCap AB | 7.25B |
| CellaVision AB | 3.57B |
| BICO Group AB | 1.29B |